Global Live Attenuated Vaccines for Poultry Market Research Report 2024(Status and Outlook)

Global Live Attenuated Vaccines for Poultry Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Live Attenuated Vaccines for Poultry Market Size was estimated at USD 355.11 million in 2023 and is projected to reach USD 457.16 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.

This report provides a deep insight into the global Live Attenuated Vaccines for Poultry market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Live Attenuated Vaccines for Poultry Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Live Attenuated Vaccines for Poultry market in any manner.

Global Live Attenuated Vaccines for Poultry Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

MERCK

Boehringer Ingelheim

ELANCO

QYH BIOTECH

CEVA

HIPRA

Kemin Biologics

ZOETIS

Vaxxinova

PULIKE

PHIBRO ANIMAL HEALTH CORPORATION

JINYU BIOTECHNOLOGY

HARBIN PHARMACEUTICAL GROUP

MEVAC

Market Segmentation (by Type)

Spray

Eye Drop

Oral

Others

Market Segmentation (by Application)

Chicken

Cattle

Horse

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Live Attenuated Vaccines for Poultry Market

Overview of the regional outlook of the Live Attenuated Vaccines for Poultry Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Live Attenuated Vaccines for Poultry
1.2 Key Market Segments
1.2.1 Live Attenuated Vaccines for Poultry Segment by Type
1.2.2 Live Attenuated Vaccines for Poultry Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Live Attenuated Vaccines for Poultry Market Overview
2.1 Global Market Overview
2.1.1 Global Live Attenuated Vaccines for Poultry Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Live Attenuated Vaccines for Poultry Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Live Attenuated Vaccines for Poultry Market Competitive Landscape
3.1 Global Live Attenuated Vaccines for Poultry Sales by Manufacturers (2019-2024)
3.2 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Manufacturers (2019-2024)
3.3 Live Attenuated Vaccines for Poultry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Live Attenuated Vaccines for Poultry Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Live Attenuated Vaccines for Poultry Sales Sites, Area Served, Product Type
3.6 Live Attenuated Vaccines for Poultry Market Competitive Situation and Trends
3.6.1 Live Attenuated Vaccines for Poultry Market Concentration Rate
3.6.2 Global 5 and 10 Largest Live Attenuated Vaccines for Poultry Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Live Attenuated Vaccines for Poultry Industry Chain Analysis
4.1 Live Attenuated Vaccines for Poultry Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Live Attenuated Vaccines for Poultry Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Live Attenuated Vaccines for Poultry Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2019-2024)
6.3 Global Live Attenuated Vaccines for Poultry Market Size Market Share by Type (2019-2024)
6.4 Global Live Attenuated Vaccines for Poultry Price by Type (2019-2024)
7 Live Attenuated Vaccines for Poultry Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Vaccines for Poultry Market Sales by Application (2019-2024)
7.3 Global Live Attenuated Vaccines for Poultry Market Size (M USD) by Application (2019-2024)
7.4 Global Live Attenuated Vaccines for Poultry Sales Growth Rate by Application (2019-2024)
8 Live Attenuated Vaccines for Poultry Market Segmentation by Region
8.1 Global Live Attenuated Vaccines for Poultry Sales by Region
8.1.1 Global Live Attenuated Vaccines for Poultry Sales by Region
8.1.2 Global Live Attenuated Vaccines for Poultry Sales Market Share by Region
8.2 North America
8.2.1 North America Live Attenuated Vaccines for Poultry Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Live Attenuated Vaccines for Poultry Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Live Attenuated Vaccines for Poultry Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Live Attenuated Vaccines for Poultry Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Live Attenuated Vaccines for Poultry Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 MERCK
9.1.1 MERCK Live Attenuated Vaccines for Poultry Basic Information
9.1.2 MERCK Live Attenuated Vaccines for Poultry Product Overview
9.1.3 MERCK Live Attenuated Vaccines for Poultry Product Market Performance
9.1.4 MERCK Business Overview
9.1.5 MERCK Live Attenuated Vaccines for Poultry SWOT Analysis
9.1.6 MERCK Recent Developments
9.2 Boehringer Ingelheim
9.2.1 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Basic Information
9.2.2 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Overview
9.2.3 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Market Performance
9.2.4 Boehringer Ingelheim Business Overview
9.2.5 Boehringer Ingelheim Live Attenuated Vaccines for Poultry SWOT Analysis
9.2.6 Boehringer Ingelheim Recent Developments
9.3 ELANCO
9.3.1 ELANCO Live Attenuated Vaccines for Poultry Basic Information
9.3.2 ELANCO Live Attenuated Vaccines for Poultry Product Overview
9.3.3 ELANCO Live Attenuated Vaccines for Poultry Product Market Performance
9.3.4 ELANCO Live Attenuated Vaccines for Poultry SWOT Analysis
9.3.5 ELANCO Business Overview
9.3.6 ELANCO Recent Developments
9.4 QYH BIOTECH
9.4.1 QYH BIOTECH Live Attenuated Vaccines for Poultry Basic Information
9.4.2 QYH BIOTECH Live Attenuated Vaccines for Poultry Product Overview
9.4.3 QYH BIOTECH Live Attenuated Vaccines for Poultry Product Market Performance
9.4.4 QYH BIOTECH Business Overview
9.4.5 QYH BIOTECH Recent Developments
9.5 CEVA
9.5.1 CEVA Live Attenuated Vaccines for Poultry Basic Information
9.5.2 CEVA Live Attenuated Vaccines for Poultry Product Overview
9.5.3 CEVA Live Attenuated Vaccines for Poultry Product Market Performance
9.5.4 CEVA Business Overview
9.5.5 CEVA Recent Developments
9.6 HIPRA
9.6.1 HIPRA Live Attenuated Vaccines for Poultry Basic Information
9.6.2 HIPRA Live Attenuated Vaccines for Poultry Product Overview
9.6.3 HIPRA Live Attenuated Vaccines for Poultry Product Market Performance
9.6.4 HIPRA Business Overview
9.6.5 HIPRA Recent Developments
9.7 Kemin Biologics
9.7.1 Kemin Biologics Live Attenuated Vaccines for Poultry Basic Information
9.7.2 Kemin Biologics Live Attenuated Vaccines for Poultry Product Overview
9.7.3 Kemin Biologics Live Attenuated Vaccines for Poultry Product Market Performance
9.7.4 Kemin Biologics Business Overview
9.7.5 Kemin Biologics Recent Developments
9.8 ZOETIS
9.8.1 ZOETIS Live Attenuated Vaccines for Poultry Basic Information
9.8.2 ZOETIS Live Attenuated Vaccines for Poultry Product Overview
9.8.3 ZOETIS Live Attenuated Vaccines for Poultry Product Market Performance
9.8.4 ZOETIS Business Overview
9.8.5 ZOETIS Recent Developments
9.9 Vaxxinova
9.9.1 Vaxxinova Live Attenuated Vaccines for Poultry Basic Information
9.9.2 Vaxxinova Live Attenuated Vaccines for Poultry Product Overview
9.9.3 Vaxxinova Live Attenuated Vaccines for Poultry Product Market Performance
9.9.4 Vaxxinova Business Overview
9.9.5 Vaxxinova Recent Developments
9.10 PULIKE
9.10.1 PULIKE Live Attenuated Vaccines for Poultry Basic Information
9.10.2 PULIKE Live Attenuated Vaccines for Poultry Product Overview
9.10.3 PULIKE Live Attenuated Vaccines for Poultry Product Market Performance
9.10.4 PULIKE Business Overview
9.10.5 PULIKE Recent Developments
9.11 PHIBRO ANIMAL HEALTH CORPORATION
9.11.1 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Basic Information
9.11.2 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Overview
9.11.3 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Market Performance
9.11.4 PHIBRO ANIMAL HEALTH CORPORATION Business Overview
9.11.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments
9.12 JINYU BIOTECHNOLOGY
9.12.1 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Basic Information
9.12.2 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Overview
9.12.3 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Market Performance
9.12.4 JINYU BIOTECHNOLOGY Business Overview
9.12.5 JINYU BIOTECHNOLOGY Recent Developments
9.13 HARBIN PHARMACEUTICAL GROUP
9.13.1 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Basic Information
9.13.2 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Overview
9.13.3 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Market Performance
9.13.4 HARBIN PHARMACEUTICAL GROUP Business Overview
9.13.5 HARBIN PHARMACEUTICAL GROUP Recent Developments
9.14 MEVAC
9.14.1 MEVAC Live Attenuated Vaccines for Poultry Basic Information
9.14.2 MEVAC Live Attenuated Vaccines for Poultry Product Overview
9.14.3 MEVAC Live Attenuated Vaccines for Poultry Product Market Performance
9.14.4 MEVAC Business Overview
9.14.5 MEVAC Recent Developments
10 Live Attenuated Vaccines for Poultry Market Forecast by Region
10.1 Global Live Attenuated Vaccines for Poultry Market Size Forecast
10.2 Global Live Attenuated Vaccines for Poultry Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Live Attenuated Vaccines for Poultry Market Size Forecast by Country
10.2.3 Asia Pacific Live Attenuated Vaccines for Poultry Market Size Forecast by Region
10.2.4 South America Live Attenuated Vaccines for Poultry Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Live Attenuated Vaccines for Poultry by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Live Attenuated Vaccines for Poultry Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Live Attenuated Vaccines for Poultry by Type (2025-2030)
11.1.2 Global Live Attenuated Vaccines for Poultry Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Live Attenuated Vaccines for Poultry by Type (2025-2030)
11.2 Global Live Attenuated Vaccines for Poultry Market Forecast by Application (2025-2030)
11.2.1 Global Live Attenuated Vaccines for Poultry Sales (Kilotons) Forecast by Application
11.2.2 Global Live Attenuated Vaccines for Poultry Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings